ELOXX PHARMACEUTICALS, INC.

Analyst Reco. Eloxx Pharmaceuticals, Inc.

Equities

ELOX

US29014R2022

Market Closed - OTC Markets Other stock markets 02:48:06 2024-06-12 pm EDT			5-day change	1st Jan Change
0.745 ^USD	+6.43%		+2.57%	-37.92%

Apr. 11	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ
Mar. 13	Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $30 From $60, Maintains Outperform Rating	Nov. 02	MT
Oppenheimer Raises Eloxx Pharmaceuticals Price Target to $60 From $55, Maintains Outperform Rating	23-09-14	MT
Oppenheimer Adjusts Eloxx Pharmaceuticals' Price Target to $55 From $50, Keeps Outperform Rating	23-07-11	MT
Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $50 From $3, Maintains Outperform Rating	23-01-05	MT
Piper Sandler Adjusts Eloxx Pharmaceuticals' Price Target to $1.50 from $4, Keeps Overweight Rating	22-05-23	MT
HC Wainwright Trims Eloxx Pharmaceuticals Price Target to $0.5 From $1, Maintains Neutral Rating	22-05-09	MT
B. Riley Lowers Eloxx Pharmaceuticals' Price Target to $3 from $5 After Revising Cost Capital Assumptions, Keeps Buy Rating	22-01-24	MT
Oppenheimer Initiates Coverage on Eloxx Pharmaceuticals With Outperform Rating, $4 Price Target	21-12-17	MT
HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $1 From $2, Keeps Neutral Rating	21-11-18	MT
HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $2 From $3, Maintains Neutral Rating	21-11-11	MT
ELOXX PHARMACEUTICALS : Mizuho Securities Starts Eloxx Pharmaceuticals at Buy With $3.10 Price Target	21-06-30	MT
ELOXX PHARMACEUTICALS : B. Riley Starts Eloxx Pharmaceuticals at Buy with $5 PT, Notes Compelling Turnaround Story	21-05-27	MT
ELOXX PHARMACEUTICALS : Piper Sandler Adjusts Price Target on Eloxx Pharmaceuticals to $4 From $6, Keeps Overweight Rating	21-05-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer